Literature DB >> 27055523

Polymorphisms in DNA Repair Gene and Susceptibility to Glioma: A Systematic Review and Meta-Analysis Based on 33 Studies with 15 SNPs in 9 Genes.

Kun Liu1,2, Yugang Jiang3.   

Abstract

At present, many publications have evaluated the correlation between the DNA repair gene polymorphisms and glioma susceptibility. However, the results remain inconclusive. The aim of this research is to exhaustively assess the association of genetic polymorphisms in DNA repair genes with glioma risk in human. Meta-analysis method was conducted, and 33 studies with 15 SNPs in 9 genes were included (12553 glioma cases and 17178 controls). Correlation strength was evaluated by odds ratio with a 95 % confidence interval. Rs1799782 T allele and rs25487A allele might bring about higher risk of glioma in Asian population. Rs1805377 G allele was an increased risk genetic factor of glioma. Asian carried with rs3212986 A allele was more likely to have glioma. Rs1800067 G allele was a risk factor of developing glioma. Carriers with rs12917 CC genotype in MGMT gene had higher risk of glioma in Caucasian than other non-CC genotype carriers. Carriers with rs1136410 T allele in PARP1 gene could more likely to develop glioma in Caucasian. This meta-analysis suggests that glioma susceptibility is associated with rs1799782 and rs25487 of X-ray repair complementing defective repair in Chinese hamster cells 1 (XRCC1), rs1805377 of XRCC4, rs1800067 of excision repair cross-complementing rodent repair deficiency complementation group 4 (ERCC4) and rs3212986 of ERCC1 in Asian population, and rs12917 of O-6-methylguanine-DNA methyltransferase (MGMT) and rs1136410 of poly(ADP-ribose) polymerase 1 (PARP1) in Caucasian population.

Entities:  

Keywords:  DNA Repair Gene; Glioma; Meta-analysis; Polymorphisms

Mesh:

Year:  2016        PMID: 27055523     DOI: 10.1007/s10571-016-0367-y

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  56 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  DNA repair gene ERCC1 and XPD polymorphisms predict glioma susceptibility and prognosis.

Authors:  Da-Qing Chen; Dong-Xiao Yao; Hong-Yang Zhao; Shu-Juan Yang
Journal:  Asian Pac J Cancer Prev       Date:  2012

3.  Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk.

Authors:  Lei Hui; Shuangzhu Yue; Guojun Gao; Haigang Chang; Xiangsheng Li
Journal:  Tumour Biol       Date:  2014-05-01

Review 4.  Genetics of adult glioma.

Authors:  McKinsey L Goodenberger; Robert B Jenkins
Journal:  Cancer Genet       Date:  2012-12-11

Review 5.  Oncomodulation by human cytomegalovirus: novel clinical findings open new roads.

Authors:  Martin Michaelis; Peter Baumgarten; Michel Mittelbronn; Pablo Hernáiz Driever; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2010-10-22       Impact factor: 3.402

6.  Role of ERCC1 promoter hypermethylation in drug resistance to cisplatin in human gliomas.

Authors:  Hua-Yun Chen; Cui-Jie Shao; Fu-Rong Chen; Aij-Lie Kwan; Zhong-Ping Chen
Journal:  Int J Cancer       Date:  2010-04-15       Impact factor: 7.396

7.  The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function.

Authors:  Kristin L Lockett; M Craig Hall; Jianfeng Xu; S Lilly Zheng; Marianne Berwick; Shu-Chun Chuang; Peter E Clark; Scott D Cramer; Kurt Lohman; Jennifer J Hu
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

8.  DNA repair gene XRCC3 variants are associated with susceptibility to glioma in a Chinese population.

Authors:  J Y Huang; J F Yang; Q Qu; J Qu; F Liu; F E Liu; T Xiong; S H Lu
Journal:  Genet Mol Res       Date:  2015-09-08

9.  MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma.

Authors:  Daina Skiriute; Paulina Vaitkiene; Viktoras Saferis; Virginija Asmoniene; Kestutis Skauminas; Vytenis Pranas Deltuva; Arimantas Tamasauskas
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

10.  DNA damage, homology-directed repair, and DNA methylation.

Authors:  Concetta Cuozzo; Antonio Porcellini; Tiziana Angrisano; Annalisa Morano; Bongyong Lee; Alba Di Pardo; Samantha Messina; Rodolfo Iuliano; Alfredo Fusco; Maria R Santillo; Mark T Muller; Lorenzo Chiariotti; Max E Gottesman; Enrico V Avvedimento
Journal:  PLoS Genet       Date:  2007-07       Impact factor: 5.917

View more
  11 in total

1.  Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).

Authors:  Stefanie Kewitz-Hempel; Lars Kurch; Michaela Cepelova; Ines Volkmer; Axel Sauerbrey; Elke Conrad; Stephanie Knirsch; Gabriele Pöpperl; Daniel Steinbach; Ambros J Beer; Christof M Kramm; Carsten-Oliver Sahlmann; Bernhard Erdlenbruch; Wolf-Dieter Reinbold; Andreas Odparlik; Osama Sabri; Regine Kluge; Martin S Staege
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

2.  PARP1 rs1136410 C/C genotype associated with an increased risk of esophageal cancer in smokers.

Authors:  Rongmiao Zhou; Yan Li; Na Wang; Chaoxu Niu; Xi Huang; Shiru Cao; Xiangran Huo
Journal:  Mol Biol Rep       Date:  2021-02-02       Impact factor: 2.316

3.  Reappraisal of XRCC1 Arg194Trp polymorphism and glioma risk: a cumulative meta-analysis.

Authors:  Jun-Ti Lu; Ai-Ping Deng; Juan Song; Li Zhang; Jie Luo
Journal:  Oncotarget       Date:  2017-03-28

4.  Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls.

Authors:  Lele Qiao; Xiaoshan Feng; Gongping Wang; Bo Zhou; Yantong Yang; Mengxiang Li
Journal:  Oncotarget       Date:  2018-01-02

5.  Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: A Case-Control Study.

Authors:  Li Yao; Linghui Zhou; Yujiao Deng; Yi Zheng; Pengtao Yang; Meng Wang; Shanshan Dong; Qian Hao; Peng Xu; Na Li; Ying Wu; Zhen Zhai; Lijuan Lyu; Zhijun Dai
Journal:  Onco Targets Ther       Date:  2019-10-07       Impact factor: 4.147

6.  CCDN1 rs603965 polymorphism may serve as a genetic biomarker of brain tumor: A meta-analysis of 5,769 subjects.

Authors:  Jiarong Lan; Min Li; Haifeng Wang
Journal:  Mol Genet Genomic Med       Date:  2019-04-10       Impact factor: 2.183

7.  The XRCC4 rs1805377 polymorphism is not associated with the risk of cancer: An updated meta-analysis.

Authors:  Xin-Yuan Zhang; Xiao-Han Wei; Bao-Jie Wang; Jun Yao
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

8.  A Novel DNA Damage Repair-Related Gene Signature for Predicting Glioma Prognosis.

Authors:  Jiaoyang Zhan; Shuang Wu; Xu Zhao; Jingjing Jing
Journal:  Int J Gen Med       Date:  2021-12-21

Review 9.  Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis.

Authors:  Xueyong Liu; Zhan Zhang; Chunbo Deng; Yihao Tian; Xun Ma
Journal:  Oncotarget       Date:  2017-07-19

10.  Long Noncoding RNA LINC00467 Promotes Glioma Progression through Inhibiting P53 Expression via Binding to DNMT1.

Authors:  Yin Zhang; Xuefeng Jiang; Zhisheng Wu; Daling Hu; Junli Jia; Jinfeng Guo; Tian Tang; Jialin Yao; Hongyi Liu; Huamin Tang
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.